These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1549692)
1. Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging. Gerard EL; Ferry JA; Amrein PC; Harmon DC; McKinstry RC; Hoppel BE; Rosen BR Radiology; 1992 Apr; 183(1):39-46. PubMed ID: 1549692 [TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of the bone marrow in patients with acute leukemia during and after chemotherapy. Changes in T1 relaxation. Jensen KE; Grundtvig Sørensen P; Thomsen C; Christoffersen P; Henriksen O; Karle H Acta Radiol; 1990 Jul; 31(4):361-9. PubMed ID: 2206692 [TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance imaging (MRI) of bone marrow necrosis]. Takasaki S; Otsuka T; Gondo H; Kamura K; Nomoto M; Kaida M; Shimoda K; Takamatsu Y; Teshima T; Nakamura M Rinsho Ketsueki; 1994 Dec; 35(12):1349-54. PubMed ID: 7861614 [TBL] [Abstract][Full Text] [Related]
5. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Johnson LA; Hoppel BE; Gerard EL; Miller SP; Doppelt SH; Zirzow GC; Rosenthal DI; Dambrosia JM; Hill SC; Brady RO Radiology; 1992 Feb; 182(2):451-5. PubMed ID: 1732964 [TBL] [Abstract][Full Text] [Related]
6. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia. Vande Berg BC; Michaux L; Scheiff JM; Malghem J; Lecouvet FE; Bourgois MP; Ferrant A; Michaux JL; Maldague BE Radiology; 1996 Nov; 201(2):519-23. PubMed ID: 8888252 [TBL] [Abstract][Full Text] [Related]
7. Lipid selective MR imaging and localized 1H spectroscopy of bone marrow during therapy of leukemia. Schick F; Einsele H; Lutz O; Claussen CD Anticancer Res; 1996; 16(3B):1545-51. PubMed ID: 8694524 [TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission. Chen BB; Hsu CY; Yu CW; Hou HA; Liu CY; Wei SY; Chou WC; Tien HF; Shih TT Radiology; 2011 Mar; 258(3):821-31. PubMed ID: 21212370 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007 [TBL] [Abstract][Full Text] [Related]
10. Repopulation of marrow after transplantation: MR imaging with pathologic correlation. Stevens SK; Moore SG; Amylon MD Radiology; 1990 Apr; 175(1):213-8. PubMed ID: 2315483 [TBL] [Abstract][Full Text] [Related]
11. [Pathomorphosis of acute leukemia]. Popov VM Sov Med; 1991; (9):15-8. PubMed ID: 1724709 [TBL] [Abstract][Full Text] [Related]
12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Betticher DC; Huxol H; Müller R; Speck B; Nissen C Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233 [TBL] [Abstract][Full Text] [Related]
13. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia. Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report. Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861 [No Abstract] [Full Text] [Related]
15. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission. Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V; Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352 [TBL] [Abstract][Full Text] [Related]
16. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959 [TBL] [Abstract][Full Text] [Related]
17. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783 [TBL] [Abstract][Full Text] [Related]
18. [MR relaxation times in diffuse bone marrow disorders: evaluation of their clinical usefulness in differentiation between leukemia and anemia]. Tanaka O; Ichikawa T; Kobayashi Y; Matsuura K; Nagai J; Takagi S Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):539-45. PubMed ID: 8797343 [TBL] [Abstract][Full Text] [Related]
19. The distribution of the magnetic field in the spine depends on the composition of bone marrow. Schick F J Magn Reson B; 1995 Jul; 108(1):1-11. PubMed ID: 7627431 [TBL] [Abstract][Full Text] [Related]
20. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Steinherz PG; Shukla N; Kobos R; Steinherz L Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]